Sobr Safe Inc is a company focused on enhancing public safety through innovative technology solutions, particularly in the area of alcohol detection and management
The firm develops advanced systems designed to promote responsible drinking and help prevent alcohol-related incidents in various settings, including workplaces and events. By integrating state-of-the-art sensors and software, Sobr Safe aims to create environments that prioritize safety and compliance while enabling organizations to monitor and manage alcohol consumption effectively. Their commitment to community well-being and operational efficiency positions them as a key player in the safety technology sector.
SOBRsafe (NASDAQSOBR) announced a strategic partnership with Orbiit, an AI-driven alcohol recovery platform, to integrate wearable alcohol detection technology with real-time behavioral support. The collaboration pairs SOBRsafe’s transdermal SOBRsure wristband with Orbiit’s AI-powered engagement platform, offering continuous monitoring, 24/7 AI support, and SMS-based accountability messaging. This initiative aims to enhance recovery outcomes by providing accessible, data-driven tools for individuals managing sobriety. The six-month Orbiit Recovery Program, priced at $3,995, includes the SOBRsure band and full platform access, marking a significant step in modernizing alcohol recovery support.
SOBR stock is trading higher on Thursday after the company announced a partnership with Orbiit to enhance alcohol recovery through AI and wearable technology.
As technology and industry trends accelerate, several innovative companies are driving transformation across key sectors such as AI, defense, 5G, and energy metals. From next-generation connectivity to breakthrough military and healthcare solutions, these companies are capturing investor attention with their disruptive potential and strong market momentum.
Peraso Inc. (NASDAQPRSO) has established itself as a global leader in 60 GHz millimeter wave (mmWave) semiconductor technology, distinguishing itself as the only publicly traded pure-play mmWave semiconductor company . Specializing in fully integrated solutions across the mmWave signal chain, Peraso provides cutting-edge performance, reliability, and cost efficiency . Its comprehensive product suite positions the company as a one-stop shop for next-generation wireless connectivity , catering to the increasing demand for high-speed, low-latency communication in applications such as drones, 5G infrastructure, and high-bandwidth networking .
SOBRsafe (NASDAQSOBR) has introduced SOBRsure, a wristband that detects alcohol through transdermal technology, offering real-time monitoring for individuals, families, and businesses. CEO David Gandini emphasized its role as both an accountability tool and a vital resource for those managing sobriety. The global drug screening market is poised for rapid growth, driven by rising substance abuse and stricter regulations. According to the World Drug Report 2023, drug use increased by 23% over a decade, while alcohol-related traffic fatalities in the U.S. rose 14% in a single year. Market forecasts project the industry to reach $19.5 billion by 2029, with North America leading the expansion. As demand for innovative screening solutions rises, SOBR Safe’s technology positions the company at the forefront of the alcohol detection market.
PALM BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the expanding consumption of illicit drugs & alcohol across the globe the Drug Screening market is poised to grow substantially in the coming years. Drug abuse and alcohol consumption are growing worldwide. According to the World Drug Report 2023, in 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The number of users grew from 240 million in 2011 to 296 million in 2021 or 5.8% of the global population aged 15-64. This is a 23% increase, partly due to population growth. Other drugs like Cannabis the second most used drug, with an estimated 219 million users i.e. 4.3% of the global adult population in 2021. In 2021, according to the US Department of Transportation, National Highway Traffic Safety Administration (NHTSA), 13,384 people died in alcohol-impaired driving crashes, i.e. a 14% rise from last year. A report from MarketsAndMarkets projected that: “The global drug screening market, valued at US$7.7 billion in 2023, is forecasted to grow at a robust CAGR of 16.6%, reaching US$9.1 billion in 2024 and an impressive US$19.5 billion by 2029.North America dominates the drug screening market. This market is projected to reach USD 9.3 billion by 2029, at a CAGR of 16.4% during the forecast period. The expanding consumption of illicit drugs & alcohol will advance raise the development of drug screening products & services on the road, thereby driving the overall market growth.” Active companies in news today include: Intelligent Bio Solutions Inc. (NASDAQINBS), Cardio Diagnostics Holdings, Inc. NASDAQ: CDIONASDAQCDIO)(NASDAQ: BIAFNASDAQBIAF, Trinity Biotech plc (NASDAQ: TRIBNASDAQ), SOBR Safe, Inc. (NASDAQ: SOBRSOBR).
SOBR Safe (NASDAQSOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection technology, recently announced the launch of its fully integrated enterprise software solution that is expected to transform how health providers monitor and manage alcohol compliance. “To complement its software solution for point-of-care screening SOBRcheck(TM) and continuous monitoring SOBRsure(TM), this enterprise software is designed to enhance responsiveness to treatment, reduce recidivism and drive positive patient outcomes,” reads an article discussing the launch.
SOBR Safe (NASDAQSOBR) (“SOBRsafe”) is a provider of next-generation transdermal alcohol screening and monitoring solutions. The company recently launched a national campaign that seeks to introduce its technology offerings – the SOBRcheck(TM) stationary alcohol screening device, the SOBRsure(TM) discreet alcohol monitoring wristband, and the SOBRsafe(TM) software platform powering reporting – to behavioral health providers and, as a result, drive sales growth into 2025. “The company aims to present its technology to over 45,000 decision-makers in the behavioral health space, having partnered with recognized leaders in public relations and digital and social media marketing,” reads an article discussing the campaign.
SOBR Safe (NASDAQSOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection solutions, earlier this year began the sale of its SOBRsure(TM) wearable continuous alcohol monitoring device in Australia and New Zealand following a 90-day proof-of-concept. “This overseas milestone was made possible through an international channel partnership with Drug Testing Business Success, the leading drug and alcohol testing service provider in the region,” reads a recent article.
